Literature DB >> 4077774

Cefamandole for the therapy of serious Staphylococcus aureus infections.

R H Eng, M L Corrado, J Tillotson, M Gombert, C Cherubin, S Landesman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4077774     DOI： 10.1093/jac/16.5.663

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

1.  Characterization of resistance phenotype and cephalosporin activity in oxacillin-resistant Staphylococcus aureus.

Authors:  M Mateos-Mora; C C Knapp; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

2.  Salt-supplemented medium for testing methicillin-resistant staphylococci with newer beta-lactams.

Authors:  J H Jorgensen; J S Redding; L A Maher; P E Ramirez
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

3.  Relationship between cefamandole and cefuroxime activity against oxacillin-resistant Staphylococcus epidermidis and oxacillin resistance phenotype.

Authors:  G L Woods; C C Knapp; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.